Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Income from Continuing Operations (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Income from Continuing Operations for 14 consecutive years, with 1437890.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 180.54% year-over-year to 1437890.0, compared with a TTM value of 6828586.0 through Dec 2025, up 5.0%, and an annual FY2025 reading of 3605374.0, up 70.73% over the prior year.
  • Income from Continuing Operations was 1437890.0 for Q4 2025 at Neuroone Medical Technologies, up from 1619221.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 1785322.0 in Q4 2024 and bottomed at 3522828.0 in Q1 2023.
  • Average Income from Continuing Operations over 5 years is 2360506.3, with a median of 2763626.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations soared 153.37% in 2024, then plummeted 180.54% in 2025.
  • Year by year, Income from Continuing Operations stood at 2807475.0 in 2021, then skyrocketed by 38.28% to 1732769.0 in 2022, then tumbled by 93.04% to 3344900.0 in 2023, then skyrocketed by 153.37% to 1785322.0 in 2024, then tumbled by 180.54% to 1437890.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for NMTC at 1437890.0 in Q4 2025, 1619221.0 in Q3 2025, and 1500868.0 in Q2 2025.